Target intelligence / Profile preview

OFD1 pseudogene 17 (OFD1P17)

Target
OFD1P17
Molecular classification
Pseudogene
01

Overview

OFD1 pseudogene 17 (OFD1P17) is a member of the OFD1 pseudogene family. Pseudogenes are DNA sequences similar to genes but typically nonfunctional; they do not produce active proteins and have lost their protein-coding potential. OFD1P17 is named for its similarity to the OFD1 gene, which is responsible for encoding a protein involved in cilia formation and human development. While the canonical OFD1 gene is linked to disorders such as oral-facial-digital syndrome type I, OFD1 pseudogenes like OFD1P17 do not have established biological activity, disease relevance, or therapeutic targeting roles[7].\n\nKey clarifications:\n- There is a risk of confusion with the canonical OFD1 gene, which is a disease-associated protein-coding gene implicated in developmental syndromes[1][3][7][8].\n- OFD1P17 is explicitly classified as a pseudogene, meaning it is not expected to be a receptor, enzyme, transporter, or any other druggable molecular target[7].\n- There are no known drugs, mechanisms of action, biomarker roles, or safety concerns associated specifically with OFD1P17[7].\n- Aliases listed overlap with other OFD1 family members or pseudogenes—appropriate caution should be taken in data mapping.\n\nThis entry should not be considered a valid molecular target for therapeutic intervention or biomarker use.

Other names
71-7A371-7A5C5orf1OFD1P1OFD1 pseudogene 1oral-facial-digital syndrome 1 pseudogeneoral-facial-digital syndrome 1pseudogene 1OFD1P17

Beyond the preview

Go deeper on OFD1 pseudogene 17 (OFD1P17).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OFD1 pseudogene 17 (OFD1P17).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call